ERBB2 and breast carcinoma: It is important to note that in SKBR3 breast cancer cells that express approximately 2 × 106 receptors/cell and are considered high (Table 1), trastuzumab induced internalization and subsequent intracellular trafficking resembles non-bound HER2 [44,46].